Literature DB >> 18207278

Neither the presence of metabolic syndrome as defined by the IDF guideline nor an increased waist circumference increased the risk of microvascular or macrovascular complications in Japanese patients with type 2 diabetes.

Tomoyuki Iwasaki1, Yu Togashi, Kenji Ohshige, Masato Yoneda, Koji Fujita, Atsushi Nakajima, Yasuo Terauchi.   

Abstract

The aim of this study was to evaluate the relationship between the diagnosis of metabolic syndrome (MetS) or its components and the prevalence of microvascular and macrovascular complications in 130 Japanese type 2 diabetic patients. Out of the 130 patients, 58.5% satisfied the criteria of the MetS as defined by the IDF guideline. The results of logistic regression analysis with adjustment for three variables (age, gender and duration of diabetes) revealed that the presence of MetS as defined by the IDF guideline was not independently related to the presence of proliferative retinopathy, proteinuria, neuropathy, or macrovascular disease in the diabetic patients. The waist circumference per se was not associated with diabetic neuropathy, retinopathy, nephropathy, or macrovascular diseases. These results suggest that neither the presence of MetS, as defined by the IDF guideline, nor the waist circumference was associated with the presence of either microvascular or macrovascular complications in Japanese type 2 diabetic patients.

Entities:  

Mesh:

Year:  2008        PMID: 18207278     DOI: 10.1016/j.diabres.2007.10.035

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  7 in total

1.  Metabolic Syndrome among Type-2 Diabetic Patients in Benghazi-Libya: A pilot study.

Authors:  Mm Alshkri; Rr Elmehdawi
Journal:  Libyan J Med       Date:  2008-12-01       Impact factor: 1.657

2.  Prevalence of Metabolic Syndrome and its influence on microvascular complications in the Indian population with Type 2 Diabetes Mellitus. Sankara Nethralaya Diabetic Retinopathy Epidemiology And Molecular Genetic Study (SN-DREAMS, report 14).

Authors:  Rajiv Raman; Aditi Gupta; Swakshyar S Pal; Suganeswari Ganesan; Kadri Venkatesh; Vaitheeswaran Kulothungan; Tarun Sharma
Journal:  Diabetol Metab Syndr       Date:  2010-11-11       Impact factor: 3.320

3.  The Association of Metabolic Syndrome with Diabetic Retinopathy: The Korean National Health and Nutrition Examination Survey 2008-2012.

Authors:  Tai Kyong Kim; Jae Yon Won; Jeong Ah Shin; Yong-Moon Park; Hyeon Woo Yim; Young-Hoon Park
Journal:  PLoS One       Date:  2016-06-08       Impact factor: 3.240

4.  Relation of metabolic syndrome and its components with risk of diabetic retinopathy: A meta-analysis of observational studies.

Authors:  Yue Zhou; Changyun Wang; Ke Shi; Xiaolong Yin
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

5.  Cardio-metabolic features of type 2 diabetes subjects discordant in the diagnosis of metabolic syndrome.

Authors:  Sa Rah Lee; Ying Han; Ja Won Kim; Ja Young Park; Ji Min Kim; Sunghwan Suh; Mi-Kyoung Park; Hye-Jeong Lee; Duk Kyu Kim
Journal:  Diabetes Metab J       Date:  2012-10-18       Impact factor: 5.376

6.  The significance of screening for microvascular diseases in Chinese community-based subjects with various metabolic abnormalities.

Authors:  Can Pang; Lili Jia; Xuhong Hou; Xin Gao; Wei Liu; Yuqian Bao; Weiping Jia
Journal:  PLoS One       Date:  2014-05-16       Impact factor: 3.240

7.  High Prevalence of Diabetic Retinopathy in Diabetic Patients Concomitant with Metabolic Syndrome.

Authors:  Lu Gao; Zhong Xin; Ming-Xia Yuan; Xi Cao; Jian-Ping Feng; Jing Shi; Xiao-Rong Zhu; Jin-Kui Yang
Journal:  PLoS One       Date:  2016-01-08       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.